Anti-aging research is gaining momentum with startups developing therapies to reverse cellular aging. Firms like Altos Labs and Cambrian Bio showcase methods such as partial epigenetic reprogramming and gene therapy that could extend healthspan. This Zephyrnet article, dated April 8, 2025, outlines substantial investments and pioneering use cases attracting industry attention.